From: Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
Conditiona
t [h]
T [°C]
Protease inhibitor [Y/N]
Control
0.5
4
Y
1A
N
1B
1
1C
1D
22
2A
O/N
60
2B
2C
2D
30
2E
2F
2G
2H
45
2I
2 J
2 K
2L
2 M